Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753336 · ClinicalTrials.gov registry record · Phase 3
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
A Phase 3 study, sponsored by Ipsen.
- Completed
- Registry status
- Phase 3
- Development phase
- 112
- Enrollment target
NCT01753336 is a Phase 3 study that has completed, run by Ipsen. The registered enrollment target is 112 participants.
The verdict
NCT01753336, a Phase 3 study, has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 112 participants
- Enrollment target
Study Summary
The purpose of the protocol is to assess the long term safety of repeat treatment cycles of Dysport® 500 U using 2 mL dilution scheme for the treatment of Cervical Dystonia. This is an extension study to study A-TL-52120-169 (hereafter referred to as Study 169).
Interventions
- BIOLOGICAL Botulinum toxin type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01753336
The ClinicalTrials.gov registry entry for NCT01753336 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Botulinum toxin type A is the first listed.
NCT01753336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01753336 about?
NCT01753336 is a clinical study titled "Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia". The purpose of the protocol is to assess the long term safety of repeat treatment cycles of Dysport® 500 U using 2 mL dilution scheme for the treatment of Cervical Dystonia. This is an extension study to study A-TL-52120-169 (hereafter referred to as Study 169).
What is the current status of trial NCT01753336?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 112 participants. The study started on 2013-03. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01753336?
The interventions under investigation include: Botulinum toxin type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT01753336?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.